| |||
 | |||
 |
Creatine | ||
|
Tyrosine | ||
| |||
|
| Pronunciation |
 (brome
fen IR a meen, fen il proe pa
NOLE a meen, & KOE deen) |
 |
| U.S. Brand Names |
| Bromanate® DC; Bromphen® DC w/Codeine; Dimetane®-DC; Myphetane DC®; Poly-Histine CS® |
|
| Generic Available |
|
Yes |
|
| Synonyms |
| Codeine, Brompheniramine, and Phenylpropanolamine; Phenylpropanolamine, Brompheniramine, and Codeine |
|
| Pharmacological Index |
|
Antihistamine/Decongestant/Antitussive |
|
| Use |
|
Relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold |
|
| Restrictions |
|
C-V |
|
| Pregnancy Risk Factor |
|
C |
|
| Drug Interactions |
|
CNS depressants, MAO inhibitors, sympathomimetics, Rauwolfia alkaloids, tricyclic antidepressants, ganglionic blocking agents, propranolol |
|
| Usual Dosage |
|
Oral: 2-6 years: 2.5 mL every 4 hours 6-12 years: 5 mL every 4 hours Children >12 years and Adults: 10 mL every 4 hours |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
Brompheniramine: No information available to require special precautions Phenylpropanolamine: Use with caution since phenylpropanolamine is a sympathomimetic amine which could interact with epinephrine to cause a pressor response |
|
| Dental Health: Effects on Dental Treatment |
|
Brompheniramine: Prolonged use may decrease salivary flow Codeine: <1%: Dry mouth Phenylpropanolamine: Up to 10% of patients could experience tachycardia, palpitations, and dry mouth; use vasoconstrictor with caution |
|
| Patient Information |
|
See individual agents. Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend to be pregnant. Do not breast-feed. |
|
| Dosage Forms |
|
Liquid: Brompheniramine maleate 2 mg, phenylpropanolamine hydrochloride 12.5 mg, and codeine phosphate 10 mg per 5 mL with alcohol 0.95% (480 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
